Top accelerator startups

14,448 startups · 29 programs

Auricle

Active · Neurostimulation implant to restore hearing & speech understanding

7signal of 100 · rising 1
  • went through YCProgram · this site+4
  • team of 2Team size · YC's directory+2.5

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W21

All of W21

About Auricle

Auricle is a medical device company building a breakthrough neurostimulation implant to restore hearing in millions of patients who no longer benefit from hearing aids, get less than 60% on a word recognition test, but aren't prepared to make the jump to a cochlear implant. Our approach preserves remaining natural hearing through a reversible and less invasive surgery, addressing the key concerns that hold most patients back from getting a cochlear implant (currently the only treatment option for these patients). The company spun out of Stanford Biodesign having completed two acute human clinical studies demonstrating the approach will work. The team is now focused on developing their full implant system for their first clinical trial. Auricle addresses a currently unserved profile of hearing loss that affects a growing population of 3.5 million patients in the US and represents an immediately accessible $1.2B market opportunity with existing reimbursement.

YC batch
W21 · Winter 2021
Status, per YC
Active
Category
Other
Team size
2
Location
San Francisco, CA, USA; Oakland, CA, USA
Checked
6h ago

YC tags: Hard Tech, Neurotechnology, Health Tech, Medical Devices, Healthcare

Auricle in W21: 336 companies, 30% AI

Auricle: questions

Which YC batch was Auricle in?

Auricle was in Y Combinator's Winter 2021 batch (W21).

Is Auricle still active?

Y Combinator lists Auricle as active.

Where is Auricle based?

Auricle lists San Francisco, CA, USA; Oakland, CA, USA as its location on YC's directory.